Abstract:Evaluate the possible value of FasL in gastric cancer gene therapy by investigating the effects of FasL expression on human gastric cancer cell line.An adenoviral vector encoding the full-length human FasL cDNA was constructed and used to infect a human gastric cancer (SGC-7901) cell line. FasL expression was confirmed by X-gal staining, flow cytometric analysis and RT-PCR. The effect of FasL on cell proliferation was determined by clonogenic assay, cytotoxicity was detected by MTT assay, and cell viability was measured by trypan blue exclusion. The therapeutic efficiency of Ad-FasL in in vivo was investigated with a xenograft tumor model in nude mice.SGC-7901 cells infected with Ad-FasL showed increased expression of FasL, resulting in significantly decreased cell growth and colony-forming activity when compared with control adenovirus-infected cells. The cytotoxicity of anti-Fas antibody (CH-11) in gastric cancer cells was stronger than that of ActD (91plusmn8 vs 60plusmn5, P<0.01), and the cytotoxicity of Ad-FasL was stronger than that of CH-11 (60plusmn5 vs 50plusmn2, P<0.05). In addition, G1-phase arrest (67.75plusmn0.39 vs 58.03plusmn2.16, P<0.05) and apoptosis were observed in Ad-FasL-infected SGC-7901 cells, and the growth of SGC-7901 xenografts in nude mice was retarded after intra-tumoral injection with Ad-FasL (54% vs 0%, P<0.0001).Infection of human gastric carcinoma cells with Ad-FasL induces apoptosis, indicating that this target gene might be of potential value in gene therapy for gastric cancer.

Construction of Replication-defective Adenovirus Vector Containing Human Fas Ligand Gene and Its Expression

Construction of recombinant adenovirus coding for the cDNA of human acidic fibroblast growth factor and the research of its gene transfection efficiency and safety

Construction and identification of replication deficient recombinant adenovirus encoding F gene of subgroup A human respiratory syncytial virus]

Construction and Identification of Polycistron Adenoviral Expression Vector PCA13/FasL-IRES-iNOS.

[Construction of FAS-targeted RNAi-retroviral Vector and Its Identification for Biological Activity].

Construction of FasL Sirna Expression Vector and Its Expression in Lung Cancer Cell Line A549

Construction of Recombinant Adenoviras Expressing RSV F Gene

The expression and application of human Fas ligand in E.coli

Construction of Fas Targeting Sirna-Expressing Vector and Its Apoptotic Inhibitory Effect

Construction of Fas gene positive cervical carcinoma cell line

Construction, Expression, Purification and Polyclonal Antibody Preparation of Fas Extracellular Region Gene

[Construction and Preparation of Helper-Dependent Adenoviral Vector Expressing Human Respiratory Syncytial Virus F Gene].

Effects of Human Lung Cancer A549 Cell Line by FasL Gene Transduction

Construction and Expression of Recombinant Adenovirus Containing Human Thymic Stromal Lymphopoietin Gene

[The cloning of mouse FasL gene and expression in chondrocytes].

Construction of replication-defective adenovirus carring human CTLA4-Ig recombinant fusion gene and its expression

Clone, Construction, and Expression of Eukaryotic Expression Vector Containing F Gene of Human Respiratory Syncytial Virus Subgroup A

Development of retroviral vectors containing rat Fas ligand gene and FasL expression mediated by the vectors in hepatocellular carcinoma cells

Construction of Recombinant Adenovirus Vector Containing Human Survivin Gene and Expression in Fibroblast

Adenovirus-Mediated FasL Gene Transfer into Human Gastric Carcinoma

[Construction of adenoviral vector encoding soluble human TNFRI-IgGFc cDNA and its expression in human bronchial epithelial cells].